End-of-day quote
Korea S.E.
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
11,340
KRW
|
-0.96%
|
|
-7.43%
|
-50.37%
|
Mar. 27 |
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
|
CI
| Mar. 25 |
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
|
CI
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
285,425
|
354,619
|
377,240
|
325,683
|
349,240
|
175,003
|
-
|
-
|
Enterprise Value (EV)
2 |
285.4
|
337.9
|
350.4
|
372.7
|
407.5
|
207
|
175
|
175
|
P/E ratio
|
24.7
x
|
44.9
x
|
-28,350
x
|
44.3
x
|
-163
x
|
17.5
x
|
5.85
x
|
7.31
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.91
x
|
6.42
x
|
4.18
x
|
2.52
x
|
2.39
x
|
1.16
x
|
0.79
x
|
0.72
x
|
EV / Revenue
|
3.91
x
|
6.12
x
|
3.88
x
|
2.89
x
|
2.79
x
|
1.38
x
|
0.79
x
|
0.72
x
|
EV / EBITDA
|
18.4
x
|
37.7
x
|
38.5
x
|
16.5
x
|
27.6
x
|
9.63
x
|
3.93
x
|
4.07
x
|
EV / FCF
|
60.1
x
|
-176
x
|
-33.8
x
|
-10.2
x
|
-16.2
x
|
3.91
x
|
8.75
x
|
6.48
x
|
FCF Yield
|
1.66%
|
-0.57%
|
-2.96%
|
-9.85%
|
-6.16%
|
25.6%
|
11.4%
|
15.4%
|
Price to Book
|
4.96
x
|
5.43
x
|
3.93
x
|
2.88
x
|
2.74
x
|
1.32
x
|
0.96
x
|
1.02
x
|
Nbr of stocks (in thousands)
|
13,307
|
13,307
|
13,307
|
13,627
|
15,284
|
15,432
|
-
|
-
|
Reference price
3 |
21,450
|
26,650
|
28,350
|
23,900
|
22,850
|
11,340
|
11,340
|
11,340
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
73.07
|
55.2
|
90.34
|
129
|
145.9
|
150.4
|
222.2
|
242
|
EBITDA
1 |
15.47
|
8.959
|
9.099
|
22.54
|
14.74
|
21.5
|
44.5
|
43
|
EBIT
1 |
12.86
|
4.581
|
3.401
|
16.21
|
6.118
|
13.75
|
37.3
|
34.5
|
Operating Margin
|
17.6%
|
8.3%
|
3.76%
|
12.56%
|
4.19%
|
9.15%
|
16.79%
|
14.26%
|
Earnings before Tax (EBT)
1 |
13.28
|
8.865
|
-2.751
|
11.47
|
-4.154
|
13.5
|
36.75
|
34
|
Net income
1 |
11.27
|
7.904
|
0.0531
|
7.957
|
-3.733
|
10.35
|
29.68
|
25.5
|
Net margin
|
15.42%
|
14.32%
|
0.06%
|
6.17%
|
-2.56%
|
6.88%
|
13.36%
|
10.54%
|
EPS
2 |
868.4
|
594.0
|
-1.000
|
539.0
|
-140.0
|
648.8
|
1,938
|
1,552
|
Free Cash Flow
3 |
4,745
|
-1,920
|
-10,364
|
-36,694
|
-25,083
|
53,000
|
20,000
|
27,000
|
FCF margin
|
6,494.4%
|
-3,478.09%
|
-11,472.59%
|
-28,445.39%
|
-17,193.88%
|
35,251.08%
|
9,001.91%
|
11,157.02%
|
FCF Conversion (EBITDA)
|
30,672.87%
|
-
|
-
|
-
|
-
|
246,511.63%
|
44,943.82%
|
62,790.7%
|
FCF Conversion (Net income)
|
42,106.61%
|
-
|
-
|
-
|
-
|
512,077.29%
|
67,396.8%
|
105,882.35%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
26.58
|
17.63
|
31.16
|
32.99
|
47.22
|
20.02
|
39.36
|
38.54
|
47.96
|
17.37
|
29.3
|
44
|
59.1
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-6.415
|
-0.9331
|
3.332
|
4.242
|
9.565
|
-4.316
|
3.331
|
4.008
|
3.095
|
-6.719
|
4.9
|
7
|
11
|
Operating Margin
|
-24.13%
|
-5.29%
|
10.69%
|
12.86%
|
20.25%
|
-21.55%
|
8.46%
|
10.4%
|
6.45%
|
-38.69%
|
16.72%
|
15.91%
|
18.61%
|
Earnings before Tax (EBT)
1 |
-10.78
|
-
|
-
|
3.984
|
8.448
|
-
|
-
|
3.92
|
-7.146
|
-5.467
|
4.1
|
10.2
|
18.9
|
Net income
1 |
-8.088
|
-
|
-
|
2.497
|
5.497
|
-2.864
|
1.331
|
3.554
|
-4.167
|
-5.437
|
2
|
6.2
|
2.4
|
Net margin
|
-30.42%
|
-
|
-
|
7.57%
|
11.64%
|
-14.3%
|
3.38%
|
9.22%
|
-8.69%
|
-31.3%
|
6.83%
|
14.09%
|
4.06%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-190.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/22
|
5/13/22
|
7/19/22
|
10/31/22
|
2/14/23
|
5/12/23
|
8/11/23
|
11/13/23
|
2/15/24
|
5/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
47
|
58.2
|
32
|
-
|
-
|
Net Cash position
1 |
-
|
16.7
|
26.8
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
2.084
x
|
3.95
x
|
1.488
x
|
-
|
-
|
Free Cash Flow
2 |
4,745
|
-1,920
|
-10,364
|
-36,694
|
-25,083
|
53,000
|
20,000
|
27,000
|
ROE (net income / shareholders' equity)
|
27%
|
12.9%
|
-0.02%
|
6.67%
|
-3.03%
|
8.15%
|
17.4%
|
15.1%
|
ROA (Net income/ Total Assets)
|
19.1%
|
9.53%
|
-0.01%
|
3.98%
|
-1.55%
|
3.8%
|
9.83%
|
8.1%
|
Assets
1 |
59
|
82.93
|
-552.8
|
199.8
|
240.9
|
272.4
|
302
|
314.8
|
Book Value Per Share
3 |
4,324
|
4,907
|
7,217
|
8,300
|
8,327
|
8,575
|
11,773
|
11,159
|
Cash Flow per Share
3 |
500.0
|
-
|
801.0
|
-558.0
|
-1,482
|
4,280
|
2,090
|
2,946
|
Capex
1 |
-
|
4.82
|
21.5
|
31.3
|
2.29
|
7.67
|
11
|
11
|
Capex / Sales
|
-
|
8.74%
|
23.84%
|
24.28%
|
1.57%
|
5.1%
|
4.95%
|
4.55%
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
11,340
KRW Average target price
30,800
KRW Spread / Average Target +171.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -50.37% | 129M | | -8.74% | 14.14B | | -45.12% | 2.51B | | -18.54% | 2.29B | | -18.03% | 1.36B | | -.--% | 1.12B | | +91.54% | 508M | | +33.28% | 491M | | +27.74% | 285M | | +2.58% | 237M |
Medical Imaging Systems
|